Home
/
Conditions
/ Andropause
Hormonal Health
Schedule a Consultation
Andropause
Andropause, or age-related testosterone decline, is the male hormonal transition that receives far less clinical attention than female menopause despite its equivalent consequences for energy, body composition, cardiovascular health, cognitive function, and quality of life. Unlike female menopause, andropause is gradual, variable, and highly modifiable through both lifestyle intervention and targeted hormone optimization.
Hormonal HealthMen's HealthOptimizable
1% Per Yearaverage testosterone decline after age 30
40%of men over 45 have clinically low testosterone by standard criteria
Gradualthe slow onset of andropause allows root cause correction to restore meaningful levels before replacement is required
← Back to Conditions
Condition: Andropause (Male Hormone Decline) | Category: Hormonal Health | Also addressed: Late-Onset Hypogonadism, Testosterone Deficiency Syndrome
What Is Andropause?
Andropause refers to the gradual, age-related decline in male sex hormones, particularly testosterone, that typically begins in a man's 30s and continues through his 40s, 50s, and beyond. Unlike the relatively abrupt hormonal shift of female menopause, andropause unfolds slowly, often making it difficult for men to recognize that their symptoms are hormonally driven rather than simply signs of aging.
Testosterone is the primary anabolic hormone in men, governing muscle mass, bone density, libido, mood, cognitive sharpness, red blood cell production, and metabolic health. Beginning around age 30, total testosterone levels decline at roughly 1 to 2 percent per year. Free testosterone, the biologically active fraction, tends to decline faster because sex hormone-binding globulin (SHBG) rises with age, binding more testosterone and leaving less available to tissues.
While some degree of hormonal change is a normal part of male aging, the rate and severity of decline vary enormously between individuals, and many men experience symptoms that significantly impair quality of life long before reaching conventional thresholds for hypogonadism.
Key principle: Andropause is not simply about the testosterone number on a lab report. A man with total testosterone of 450 ng/dL and an SHBG of 65 nmol/L may have free testosterone in the bottom 10 percent of reference range. Without measuring free testosterone and SHBG, the most clinically significant cases are entirely invisible to standard evaluation.
Why It Matters
Testosterone deficiency is associated with increased cardiovascular risk, insulin resistance, accelerated bone loss, cognitive decline, and all-cause mortality. Yet the majority of men with symptomatic andropause are told their labs are normal because the evaluation never goes beyond a single total testosterone measurement.
The Clinical Burden of Undertreated Andropause
- Testosterone deficiency accelerates muscle loss, fat accumulation, insulin resistance, and cardiovascular risk independently of other risk factors
- Depression, anxiety, and relationship difficulties often have an unrecognized hormonal component in middle-aged men
- Most men with symptomatic andropause are told their labs are normal despite suffering from suboptimal hormone levels
- Untreated, low testosterone accelerates sarcopenia, visceral adiposity, and metabolic syndrome in a self-amplifying cycle
Why Conventional Medicine Often Misses It
- Standard labs only check total testosterone, missing free and bioavailable fractions
- Reference ranges are broad population averages, not optimal health targets
- Estradiol, SHBG, LH, FSH, and DHT are rarely evaluated together as a unified hormonal picture
- Root causes including sleep disruption, insulin resistance, and nutrient deficiencies go unaddressed even when testosterone is treated
Common Symptoms
Andropause symptoms span metabolic, neurological, and sexual domains and are frequently attributed to normal aging, depression, or overwork rather than identified as hormonally driven.
Metabolic and Physical
- Loss of muscle mass and strength despite consistent exercise
- Increased abdominal fat accumulation independent of diet
- Reduced bone density and joint discomfort
- Reduced exercise tolerance and prolonged recovery
Neurological and Mood
- Fatigue and low energy, especially in afternoons
- Cognitive fog, poor concentration, and word-finding difficulty
- Mood changes, irritability, and depression
- Sleep disturbance and poor overnight recovery
Sexual and Hormonal
- Reduced libido and sexual drive
- Erectile dysfunction or reduced quality of erections
- Hot flashes or night sweats (less common but present)
- Reduced testicular volume with advancing decline
Root Causes: A Functional Medicine Perspective
Andropause is rarely purely an age-driven phenomenon. Multiple modifiable drivers accelerate or amplify hormonal decline, and identifying them is essential for meaningful treatment.
Insulin Resistance and Metabolic Dysfunction
Insulin resistance and visceral adiposity are among the most significant and modifiable drivers of low testosterone. Visceral fat aromatizes testosterone to estradiol via the aromatase enzyme, and high insulin directly suppresses Leydig cell testosterone production. This creates a self-perpetuating cycle: low testosterone promotes fat gain, and fat gain further lowers testosterone. Addressing insulin resistance frequently produces 100 to 250 ng/dL improvements in total testosterone without any hormonal therapy.
Chronic Sleep Deprivation
The bulk of daily testosterone production occurs during deep sleep, particularly in the early morning hours. Men sleeping fewer than six hours per night show measurably lower testosterone than those sleeping seven to nine hours. Sleep deprivation is one of the most powerful modifiable suppressors of testosterone and is almost never addressed before hormonal therapy is prescribed.
HPA Axis Dysfunction and Chronic Stress
Chronic psychological stress elevates cortisol, which competitively inhibits testosterone production at the Leydig cell level and suppresses LH pulsatility from the hypothalamus. Men with high occupational stress, poor sleep, and elevated cortisol have testosterone levels measurably below their physiological potential. Cortisol and testosterone share biosynthetic precursors, and chronic demand for cortisol reduces substrate availability for testosterone synthesis.
Nutritional Deficiencies
Zinc, magnesium, vitamin D, and selenium are direct cofactors in testosterone biosynthesis. Zinc deficiency is extraordinarily common in men with low testosterone and impairs the enzymatic pathways required for testosterone production. Vitamin D acts through dedicated receptors on Leydig cells. Repleting these nutrients before initiating testosterone replacement therapy frequently reduces the dose required and in some cases restores testosterone to therapeutic ranges without exogenous hormones.
Conventional vs Functional Medicine Approach
| Domain | Conventional Medicine | Functional Medicine |
|---|---|---|
| Lab evaluation | Total testosterone only; treatment initiated if below 300 ng/dL | Free testosterone, SHBG, estradiol, LH, FSH, DHT, prolactin, fasting insulin, vitamin D, and zinc as a unified panel |
| Root cause assessment | Not standard; lifestyle mentioned but not clinically operationalized | Sleep quality, insulin resistance, cortisol pattern, nutritional status, and toxic load evaluated as modifiable drivers before hormonal intervention |
| Treatment threshold | Below 300 ng/dL total testosterone | Optimization to physiologic peak ranges based on symptom burden and free testosterone, not just total testosterone cutoffs |
| Fertility considerations | Rarely addressed; TRT suppresses LH and sperm production without warning | HCG co-administration or clomiphene alternatives offered for men desiring fertility preservation |
| Monitoring | Total testosterone and PSA; variable frequency | Full hormone panel, hematocrit, PSA, metabolic markers, and symptom assessment at regular intervals |
Key Labs to Evaluate
A complete andropause evaluation requires markers that characterize both the hormonal deficit and the upstream drivers producing it.
| Marker | Conventional Range | Functional Target | Clinical Significance |
|---|---|---|---|
| Total Testosterone | 300-1000 ng/dL | 600-900 ng/dL | Primary androgen; must evaluate alongside free fraction and SHBG |
| Free Testosterone | 5-21 pg/mL | 15-25 pg/mL | Biologically active fraction; more clinically relevant than total alone |
| SHBG | 10-57 nmol/L | 20-40 nmol/L | Elevated SHBG reduces free testosterone despite normal-appearing total |
| Estradiol (E2) | 10-40 pg/mL | 20-30 pg/mL | Elevated E2 suppresses LH and drives gynecomastia and mood symptoms |
| LH / FSH | 1.5-9.3 / 1.5-12.4 mIU/mL | Mid-range | Differentiates primary vs secondary hypogonadism |
| DHT | 30-85 ng/dL | 40-70 ng/dL | Active androgen required for libido, mood, and prostate context |
| Prolactin | Below 15 ng/mL | Below 10 ng/mL | Elevated prolactin suppresses LH and testosterone production |
| Fasting Insulin / HOMA-IR | Insulin below 25 uIU/mL | Below 8 uIU/mL | Insulin resistance directly suppresses testosterone synthesis |
| Vitamin D (25-OH) | 30-100 ng/mL | 60-80 ng/mL | VDR signaling on Leydig cells; low D correlates with low testosterone |
| Zinc (RBC) | Lab-dependent | Upper quartile | Direct cofactor in testosterone biosynthesis; commonly deficient |
How to Interpret These Labs Together
Low free testosterone with elevated SHBG and normal-appearing total testosterone is the most commonly missed andropause presentation. The total testosterone reads within range while free testosterone is critically low. This pattern often correlates with thyroid dysfunction, liver burden, or age-related SHBG rise. Without measuring both free testosterone and SHBG simultaneously, this pattern is entirely invisible.
Low LH and FSH alongside low testosterone points to secondary (central) hypogonadism, meaning the problem originates in the hypothalamic-pituitary axis. Chronic stress, opioid use, sleep apnea, and prolactinoma are common causes. This pattern requires different treatment than primary testicular failure.
| Pattern | Clinical Implication |
|---|---|
| Low free T, elevated SHBG, normal total T | Most commonly missed andropause presentation. Free testosterone critically low despite normal-appearing total. Address SHBG drivers before considering TRT. |
| Low T with low LH and FSH | Secondary hypogonadism. Pituitary signaling is inadequate. Evaluate for chronic stress, sleep apnea, prolactinoma, or opioid use. Clomiphene or HCG-based protocols often preferred over direct TRT. |
| Low T with elevated LH and FSH | Primary testicular failure. Pituitary signaling appropriately but testes are not responding. More likely to require direct testosterone support. |
| Elevated estradiol relative to testosterone | Accelerated aromatization, often driven by visceral adiposity. Addressing body composition and potentially using targeted aromatase modulation shifts this ratio. |
| Low DHT with adequate total testosterone | Impaired 5-alpha reductase activity. Explains persistent libido and mood symptoms despite adequate total testosterone levels. |
Common Patterns Seen in Patients
- The man whose testosterone is "normal" but is anything but: total testosterone of 450 ng/dL, SHBG of 65 nmol/L, free testosterone in the bottom 10 percent of range; prescribed antidepressants for symptoms that are fundamentally hormonal; no one has ever checked his fasting insulin
- The high-stress professional with compounding drivers: low-normal testosterone, high cortisol, poor sleep, and insulin resistance where all four variables feed each other; metabolic optimization alone restores 150 to 250 ng/dL of testosterone before any hormonal therapy is needed
- The fitness-focused man with training-suppressed testosterone: intense training and caloric restriction have suppressed LH and driven testosterone below his baseline; standard evaluation misses this because the labs appear borderline rather than diagnostic
- The man whose symptoms are in the DHT domain: testosterone appears adequate but DHT is low, explaining persistent libido and mood symptoms that do not respond to testosterone optimization alone
Treatment and Optimization Strategy
Lifestyle and Nutritional Foundation
- Prioritize 7-9 hours of sleep as a non-negotiable hormonal intervention before any other treatment
- Resistance training 3-4 times per week with compound movements; avoid chronic overtraining
- Reduce visceral fat through dietary carbohydrate optimization and caloric balance
- Optimize zinc, magnesium, vitamin D, and selenium through food and targeted supplementation
- Reduce xenoestrogen exposure through filtered water, glass food storage, and organic food where feasible
Clinical and Hormonal Interventions
- Testosterone replacement therapy via cypionate, enanthate, or pellets when clinically indicated and root causes addressed
- Clomiphene or enclomiphene to stimulate endogenous LH in men with secondary hypogonadism
- HCG to maintain testicular volume and fertility during TRT
- Aromatase inhibition when estradiol is disproportionately elevated relative to testosterone
- Ongoing monitoring of hematocrit, PSA, and full hormone panel every 6-12 months on therapy
What Most Doctors Miss
- Free testosterone and SHBG are not measured: treating total testosterone as a sufficient measure of hormonal health misses the most common presentation of andropause; without SHBG and free testosterone, the majority of clinically significant cases are invisible to standard evaluation
- Estradiol balance is neglected: men need estradiol for bone density, cardiovascular protection, and libido, but when disproportionately elevated relative to testosterone it suppresses LH pulsatility and worsens all andropause symptoms; the testosterone-to-estradiol ratio matters as much as the absolute testosterone level
- Insulin resistance as a root cause is not evaluated or addressed: prescribing testosterone without addressing the underlying metabolic driver leaves the root cause unresolved and may worsen insulin resistance over time by further suppressing LH
- Sleep is not assessed or addressed as a primary intervention: men losing one to two hours of sleep per night are losing a meaningful fraction of their daily testosterone production; no hormone therapy compensates for chronic sleep deprivation
- Nutritional cofactors for testosterone synthesis are not tested: zinc, vitamin D, and magnesium deficiencies impair testosterone production enzymatically; repleting them before initiating TRT often produces meaningful testosterone improvement
When to Seek Medical Care
Men experiencing significant fatigue, libido decline, mood changes, or body composition shifts that are interfering with daily function should seek evaluation rather than attributing symptoms to normal aging. These symptoms are common but not inevitable, and in many cases are meaningfully reversible.
Seek prompt evaluation if you experience symptoms alongside breast tissue enlargement, testicular atrophy, infertility, or headaches with visual changes, which may indicate a pituitary mass requiring imaging before any hormonal treatment is initiated.
Recommended Testing
Identifying the root cause of this condition requires going beyond standard labs. The following markers provide the most clinically useful insights.
Foundational Labs
- Total Testosterone
- Free Testosterone
- SHBG
- Estradiol (E2)
Advanced Assessment
- LH / FSH
- DHT
- Prolactin
- Fasting Insulin / HOMA-IR
- Vitamin D
- Zinc (RBC)
Recommended Panel
Hormone Optimization Panel
Complete sex hormone evaluation including free and total testosterone, estradiol, SHBG, LH, FSH, DHT, prolactin, and DHEA-S.
→
Not sure which testing applies to you?
Explore All Testing Options →Frequently Asked Questions
Is andropause a real medical condition?
Yes. While less abrupt than female menopause, the gradual decline of testosterone and other hormones in aging men is well-documented and can significantly impair quality of life and long-term health. It is recognized under various clinical terms including late-onset hypogonadism and testosterone deficiency syndrome.
What testosterone level is considered low?
Conventional medicine typically uses 300 ng/dL as the cutoff for hypogonadism, but functional medicine evaluates the full picture including free testosterone, SHBG, and symptom burden. Many men feel significantly impaired with total testosterone between 300 and 500 ng/dL, particularly when free testosterone is low and SHBG is elevated.
Will testosterone therapy affect my fertility?
Exogenous testosterone suppresses LH and FSH, reducing sperm production and potentially impairing fertility. Men who wish to preserve fertility should discuss alternatives such as clomiphene or HCG-based protocols, which stimulate endogenous production without suppressing the hypothalamic-pituitary axis.
Can lifestyle changes actually raise testosterone?
Yes, meaningfully so. Improving sleep quality, reducing insulin resistance, losing visceral fat, optimizing zinc and vitamin D, and reducing chronic stress can collectively raise testosterone by 100 to 300 ng/dL in some men, occasionally eliminating the need for hormone therapy altogether.
Is testosterone therapy safe long-term?
When properly monitored with regular labs including hematocrit, PSA, and full hormone panels, testosterone therapy has a well-established safety profile. Risks are most relevant when therapy is initiated without proper baseline evaluation or when doses are not adjusted to maintain physiologic levels.
How The Lamkin Clinic Approaches Andropause
Clinical Perspective
The men I see who have been told their testosterone is fine are often the ones suffering the most. The number on the lab report only tells part of the story. We look at the full picture, including free testosterone, SHBG, estradiol, insulin resistance, sleep quality, and what is driving the decline, before we decide on the path forward. In many cases, addressing the root causes restores testosterone meaningfully before any exogenous therapy is needed.
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
At The Lamkin Clinic, andropause evaluation begins with a comprehensive panel that goes well beyond total testosterone. We assess free testosterone, SHBG, estradiol, LH, FSH, DHT, prolactin, fasting insulin, HOMA-IR, vitamin D, zinc, and a full metabolic panel to understand the full hormonal and metabolic context. We identify and address root causes before initiating hormone therapy whenever possible.
Related Conditions
Low TestosteroneComprehensive evaluation and optimization of testosterone deficiency in men
→Insulin ResistanceMetabolic driver of testosterone suppression and visceral adiposity
→HPA Axis DysfunctionCortisol patterns that suppress testosterone production and LH pulsatility
→Visceral AdiposityExcess abdominal fat accelerating aromatization and worsening andropause
→Related Symptoms
FatiguePersistent low energy with hormonal and metabolic underpinning in andropause
→Brain FogCognitive dulling associated with testosterone and metabolic decline
→Low LibidoReduced sexual drive linked to testosterone and estradiol imbalance
→Mood ChangesIrritability and depression frequently tied to hormonal dysregulation in men
→Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.
Ready to Address Andropause at Its Root?
We provide comprehensive hormonal evaluation and personalized treatment for men experiencing andropause. Our approach addresses the full picture, including metabolic health, sleep, stress, and nutrient status, not just testosterone numbers.
Schedule a ConsultationMedical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.